Dysregulation or deletion of these genes, often observed in Y chromosome loss, has been linked to the aberrant activation of AR splice variants (e.g., AR-V7) and the NF-κB pathway, both of which contribute to the transition to castration-resistant prostate cancer [46,47]. This evidence concerns the gene AR and prostate cancer.